About Singular Genomics Systems, Inc. 
Singular Genomics Systems, Inc.
Medical Specialties
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 19 Schemes (8.55%)
Foreign Institutions
Held by 18 Foreign Institutions (4.34%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Sep 2024)
Net Profit:
-17 Million
Medical Specialties
USD 51 Million (Micro Cap)
NA (Loss Making)
NA
2,919.01%
-0.80
-70.04%
0.41






